Psyence Biomedical Ltd. Common Shares (United States) is listed on the Nasdaq and has a market capitalization of $9.66 million, with shareholders equity totaling $11.87 million.
The company employs approximately 12 people and operates in the Others sector, within the Others industry.
Over the past 12 months, Psyence Biomedical Ltd. Common Shares reported $- in revenue, generating net income of $-1.28 million.
Key financial metrics include a P/E ratio of -7.52, a price-to-book (P/B) ratio of 0.81, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker PBM.